AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2021

Oct 1, 2021

32641_dirs_2021-10-01_15395a15-28b9-43c2-8156-d91bc4af2a78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2021-09-29

Reporting Person: D'Alessandro Danilo (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-29	Common Stock	F	4958	$17.22	Disposed	33465	Direct

Footnotes

F1: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.